Montelukast vs placeboChange (improvement) in disease severity (4 to 8 weeks) SMD (modified EASI score and SASSAD) · eczema1 finding from 1 reviewLeukotriene receptor antagonists for eczema 2018 · Cochrane Headline outcomes onlyno estimate extracted3 studies · 131 participantsLow